Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Amarantus Bioscience Holdings (AMBS) Message Board

From what i understand the answer is no (99% sure)

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 30067
(Total Views: 660)
Posted On: 01/20/2018 2:49:13 AM
Avatar
Posted By: jamiejaytrader
Re: longboardsurfer90210 #25999
From what i understand the answer is no (99% sure).

We own shares of the parent company AMBS and the parent company owns ESS, ELTO and MANF.

So now AMBS parent company is lets say about 7 million worth (market cap).

Now for example, they spinoff ESS, ELTO and MANF with succes and they become their own fully owned subsidiaries led with their own managements.

So AMBS will own 3 companies.

Say ELTO is worth 20 million.
Say MANF is worth 100 million
and lets say ESS is worth 30 million after they IPO.

That means that AMBS should be worth 150 million market cap (let me remind everyone that we were worth 160 million market cap before we acquired the ESS product and were ruined because of the toxics.).

So an 150 million market cap would be around true-er value then we are right now sitting at 7 million market cap.

So that would mean if AMBS management would execute properly on their business plans then you could be looking at a 21 times higher pps then where we are now.

And thats just a normal valuation like other peer companies.

But say we also produce some good data this year (or the next) from any of our products then we could potentially be worth a whole lot more then the 150 million market cap.

Everything falls down to good execution.

I like the risk/reward scenario. There is lots of upside to the pps.

GL


(9)
(0)




Amarantus Bioscience Holdings (AMBS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us